Oxygenated fluorocarbon nutrient emulsion

Drug Profile

Oxygenated fluorocarbon nutrient emulsion

Alternative Names: Fluorocarbon emulsion; NTF 108; OFNE; Revoxyn

Latest Information Update: 11 Jun 2015

Price : $50

At a glance

  • Originator Neuron Therapeutics
  • Class Fluorocarbons
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Stroke

Most Recent Events

  • 26 Apr 2007 Phase II development is ongoing
  • 21 Jun 2001 Phase-II clinical trials for Stroke in USA (Intracerebal)
  • 13 Mar 2001 Phase-I clinical trials for Stroke in USA (Intracerebal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top